What is the primary use of Rivastigmine?

Rivastigmine is primarily used in the treatment of Alzheimer's disease, a neurodegenerative disorder that leads to progressive cognitive decline and memory loss. It is classified as a cholinesterase inhibitor, which works by increasing levels of acetylcholine, a neurotransmitter involved in memory and learning. By preventing the breakdown of acetylcholine, Rivastigmine helps to improve or stabilize cognitive function in patients with mild to moderate Alzheimer's disease.

In this context, its effectiveness in managing the symptoms of Alzheimer's disease makes it a valuable option for individuals struggling with this condition. Its role is focused on symptom management rather than curing the disease, emphasizing the importance of supportive therapies in the care of dementia patients. The other options provided do not relate to the specific mechanism of action or therapeutic goal of Rivastigmine, further affirming that its primary use is in addressing the needs of those diagnosed with Alzheimer's disease.